← Back to Search

Device

Deep Brain Stimulation for Depression

N/A
Recruiting
Led By Sameer A Sheth, MD, PhD
Research Sponsored by Baylor College of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
DSM-5 diagnosis of major depression disorder (MDD) as the primary diagnosis
Previous trial of Electroconvulsive Therapy (ECT)
Must not have
Neurological/Medical condition that makes the patient a poor surgical candidate
Medical contraindication to surgery such as infection
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 54 to 60 months
Awards & highlights
No Placebo-Only Group

Summary

This trial will test a new brain stimulator to see if it can help people with treatment-resistant depression by targeting different areas of the brain.

Who is the study for?
This trial is for adults aged 22-70 with major depressive disorder (MDD) who haven't improved after trying at least four different depression treatments and ECT or psychotherapy. They must have a stable medication regimen, normal brain MRI, no bipolar or certain personality disorders, no recent substance abuse, and not be pregnant.
What is being tested?
The study tests a new type of Deep Brain Stimulation (DBS) that directs electrical currents to specific brain networks linked to depression. It aims to show this method can change behavior by targeting these networks and is safe for long-term use in reducing symptoms of severe depression.
What are the potential side effects?
Potential side effects may include discomfort at the implant site, headache, nausea, changes in mood or sleep patterns. There's also a risk of bleeding or infection from surgery and possible device-related complications like battery failure.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with major depression as my main health issue.
Select...
I have undergone Electroconvulsive Therapy (ECT) before.
Select...
I've had at least 6 weeks of psychotherapy without feeling better.
Select...
My depression symptoms are severe, scoring 27 or higher on the MADRS.
Select...
I am between 22 and 70 years old and not pregnant.
Select...
My recent brain MRI does not show anything that would stop me from joining.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have a health condition that makes surgery risky for me.
Select...
I cannot have surgery due to a medical condition like an infection.
Select...
I have bipolar disorder with rapid mood changes and was hospitalized for a manic episode in the last 5 years.
Select...
I have high blood pressure and heart disease.
Select...
I have a history of seizures or am at high risk for seizures.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~54 to 60 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 54 to 60 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Changes in depressive symptoms

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Directional Deep Brain StimulationExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Baylor College of MedicineLead Sponsor
1,028 Previous Clinical Trials
6,030,150 Total Patients Enrolled
29 Trials studying Depression
7,110 Patients Enrolled for Depression
University of TexasOTHER
189 Previous Clinical Trials
142,956 Total Patients Enrolled
11 Trials studying Depression
1,389 Patients Enrolled for Depression
Sameer A Sheth, MD, PhDPrincipal InvestigatorBaylor College of Medicine

Media Library

Directional Deep Brain Stimulation (Device) Clinical Trial Eligibility Overview. Trial Name: NCT03437928 — N/A
Depression Research Study Groups: Directional Deep Brain Stimulation
Depression Clinical Trial 2023: Directional Deep Brain Stimulation Highlights & Side Effects. Trial Name: NCT03437928 — N/A
Directional Deep Brain Stimulation (Device) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03437928 — N/A
Depression Patient Testimony for trial: Trial Name: NCT03437928 — N/A
~3 spots leftby Aug 2026